BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26129626)

  • 1. Evaluation of the 'Prostate Interdisciplinary Communication and Mapping Algorithm for Biopsy and Pathology' (PIC-MABP).
    Junker D; Herrmann TR; Bader M; Bektic J; Henkel G; Kruck S; Sandbichler M; Schilling D; Schäfer G; Nagele U;
    World J Urol; 2016 Feb; 34(2):245-52. PubMed ID: 26129626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating multiparametric MRI for diagnosis and monitoring of prostate cancer in patients for active surveillance.
    Sahibzada I; Batura D; Hellawell G
    Int Urol Nephrol; 2016 Apr; 48(4):529-33. PubMed ID: 26759330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.
    Tewes S; Hueper K; Hartung D; Imkamp F; Herrmann TR; Weidemann J; Renckly S; Kuczyk MA; Wacker F; Peters I
    World J Urol; 2015 Nov; 33(11):1707-14. PubMed ID: 25774003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance.
    Radtke JP; Boxler S; Kuru TH; Wolf MB; Alt CD; Popeneciu IV; Steinemann S; Huettenbrink C; Bergstraesser-Gasch C; Klein T; Kesch C; Roethke M; Becker N; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
    Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):288-96. PubMed ID: 26078202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists.
    Yoo S; Kim JK; Jeong IG
    Korean J Urol; 2015 Jul; 56(7):487-97. PubMed ID: 26175867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies.
    Rastinehad AR; Waingankar N; Turkbey B; Yaskiv O; Sonstegard AM; Fakhoury M; Olsson CA; Siegel DN; Choyke PL; Ben-Levi E; Villani R
    PLoS One; 2015; 10(11):e0143404. PubMed ID: 26605548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
    Salami SS; Ben-Levi E; Yaskiv O; Ryniker L; Turkbey B; Kavoussi LR; Villani R; Rastinehad AR
    BJU Int; 2015 Apr; 115(4):562-70. PubMed ID: 25252133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].
    Kesch C; Radtke JP; Distler F; Boxler S; Klein T; Hüttenbrink C; Hees K; Roth W; Roethke M; Schlemmer HP; Hohenfellner M; Hadaschik BA
    Urologe A; 2016 Aug; 55(8):1071-7. PubMed ID: 27168038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of cognitive MRI-targeted biopsy in hitting prostate cancer-positive regions of interest.
    Cerantola Y; Haberer E; Torres J; Alameldin M; Aronson S; Levental M; Bladou F; Anidjar M
    World J Urol; 2016 Jan; 34(1):75-82. PubMed ID: 25981403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomy.
    Orczyk C; Rosenkrantz AB; Deng FM; Melamed J; Babb J; Wysock J; Kheterpal E; Huang WC; Stifelman M; Lepor H; Taneja SS
    Urol Oncol; 2016 Jan; 34(1):3.e1-8. PubMed ID: 26338414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric magnetic resonance imaging-targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results.
    Abdi H; Zargar H; Goldenberg SL; Walshe T; Pourmalek F; Eddy C; Chang SD; Gleave ME; Harris AC; So AI; Machan L; Black PC
    Urol Oncol; 2015 Apr; 33(4):165.e1-7. PubMed ID: 25665509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added Value of Multiparametric Ultrasonography in Magnetic Resonance Imaging and Ultrasonography Fusion-guided Biopsy of the Prostate in Patients With Suspicion for Prostate Cancer.
    Maxeiner A; Stephan C; Durmus T; Slowinski T; Cash H; Fischer T
    Urology; 2015 Jul; 86(1):108-14. PubMed ID: 26142593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric magnetic resonance imaging/transrectal ultrasound fusion targeted biopsy of the prostate: preliminary results of a prospective single-centre study.
    Junker D; Schäfer G; Heidegger I; Bektic J; Ladurner M; Jaschke W; Aigner F
    Urol Int; 2015; 94(3):313-8. PubMed ID: 25591786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA.
    Müller S; Lilleaasen G; Sand TE; Løfsgaard L; Estop-Garanto M; Helgø D; Sund P; Mygland V
    World J Urol; 2018 May; 36(5):687-691. PubMed ID: 29508048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
    Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
    Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric magnetic resonance imaging enhances detection of significant tumor in patients on active surveillance for prostate cancer.
    Abdi H; Pourmalek F; Zargar H; Walshe T; Harris AC; Chang SD; Eddy C; So AI; Gleave ME; Machan L; Goldenberg SL; Black PC
    Urology; 2015 Feb; 85(2):423-8. PubMed ID: 25623709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer.
    Kaufmann S; Bedke J; Gatidis S; Hennenlotter J; Kramer U; Notohamiprodjo M; Nikolaou K; Stenzl A; Kruck S
    World J Urol; 2016 Apr; 34(4):509-15. PubMed ID: 26267808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer detection using multiparametric 3 - tesla MRI and fusion biopsy: preliminary results.
    Mussi TC; Garcia RG; Queiroz MR; Lemos GC; Baroni RH
    Int Braz J Urol; 2016; 42(5):897-905. PubMed ID: 27532112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of MRI/ultrasound fusion in primary biopsy for the diagnosis of prostate cancer].
    Distler F; Radtke JP; Kesch C; Roethke M; Schlemmer HP; Roth W; Hohenfellner M; Hadaschik B
    Urologe A; 2016 Feb; 55(2):146-55. PubMed ID: 26556268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.